| Verified against primary record | |
| Workforce | Global median of 13 mental health workers per 100,000 people[1] |
|---|---|
| Spending | High-income countries up to 65 US dollars per person, low-income as little as 0.04[1] |
| Carrying medicines | Many countries do not permit more than a 30 to 90 day supply, and each regulates differently[2] |
| Records read | WHO release on the 2024 atlas and treaty body traveller guidance, 30 September 2026 |
| Independently reported | |
| Travel volume | Not measured in any source located |
| Bands apply only to the rows beneath them. The atlas figures are quoted from the publisher’s own release; the atlas itself was not read for this entry. | |
Mental health treatment abroad covers travel for psychiatric and psychological care. It differs from most treatment sectors in that the service is not a procedure but a relationship extended over time, which makes the questions of continuity, legal capacity and medication supply more central than they are elsewhere in medical travel.
The provision gradient
Reporting its 2024 mental health atlas, the World Health Organization stated that the global median number of mental health workers stands at 13 per 100,000 people, with extreme shortages in low- and middle-income countries, and that median government spending on mental health remains at just 2 per cent of total health budgets, unchanged since 2017. The spending range is extreme: high-income countries spend up to 65 United States dollars per person on mental health while low-income countries spend as little as 4 cents. In low-income countries fewer than 10 per cent of affected individuals receive care, against over 50 per cent in higher-income nations.[1]
The same release reported that more than 1 billion people are living with mental health disorders, that depression and anxiety alone cost the global economy an estimated 1 trillion United States dollars each year, and that suicide claimed an estimated 727,000 lives in 2021.[1] The first two of those are estimates rather than counts: the prevalence figure derives from modelled burden-of-disease work and the economic figure from cost modelling, and neither should be reported as measured. Only the suicide figure carries an explicit year.
Medicines that do not travel freely
A practical constraint applies to this field more than most, because many psychiatric medicines are controlled substances. The International Narcotics Control Board advises travellers that a medical prescription from a licensed doctor is required by most countries, that the prescription should be translated into the local language and that for some countries an English translation will suffice. It states that many countries do not permit carrying more than a 30 to 90 day supply, that each country regulates the matter differently so that legislation may differ greatly between them, that requirements for foreigners might differ from those for citizens, and that different requirements may apply depending on the country travelled from. Within the Schengen area a medical certificate may be issued, valid for a maximum period of 30 days.[2]
The Board attaches its own qualification to that guidance, stating that responsibility for updating information on national rules lies entirely with the governments concerned. Country-specific information from that source is therefore supplied by states rather than verified by the Board, and the 30 to 90 day range is its description of a common pattern rather than a rule.
Capacity and consent across borders
One question specific to this field is under-discussed and is flagged here rather than answered. The circumstances in which a person may be treated without consent, detained for assessment, or found to lack decision-making capacity are set by national mental health and capacity law, and those laws differ. A patient treated in another country is subject to the destination country’s framework rather than the one they know, and a safeguard available at home may have no counterpart abroad. No source establishing the comparative position was verified for this entry, so no specific national rules are described, and the point is recorded as an open question rather than as a finding.
No source located measures how many people travel abroad for mental health treatment.
See also
- Addiction treatment abroad, the closely related sector
- Medical travel and language barriers, which bear harder on talking therapies than on surgery
- Medical travel coordination, where continuity of care would have to be arranged
- Medical tourism and health equity, for the provision gradient described here
References
- World Health Organization. Over a billion people living with mental health conditions, services require urgent scale-up. 2 September 2025, reporting the Mental Health Atlas 2024 and World Mental Health Today. Verified against primary record: the publisher’s own release opened and read; the underlying reports were not read for this entry. Retrieved 30 September 2026.
- International Narcotics Control Board. General Information for Travellers. Page carries no date. Verified against primary record: treaty body guidance opened and read. Retrieved 30 September 2026.
Sourcing note: the WHO release and the treaty body guidance were opened and read on 30 September 2026. The atlas figures are attributed to the release that reports them rather than page-cited to the atlas, which was not read; the release does not state the atlas data-collection year or country response rate. The prevalence and economic cost figures are labelled as estimates. The question of capacity and involuntary treatment law across borders is recorded as an open question, because no comparative source was verified for it.